- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02245334
A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
September 18, 2014 updated by: Seoul National University Hospital
A Prospective Randomized Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
To assess the effect of povidone-iodine on infectious complication rate caused by transrectal prostate biopsy
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
the effect of povidone-iodine on infectious complication rate caused by transrectal prostate biopsy
Study Type
Interventional
Enrollment (Anticipated)
1578
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gyunggi-do
-
Seongnam, Gyunggi-do, Korea, Republic of, 463-707
- Department of Urology, Seoul National University Bundang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- who undergo transrectal prostate biopsy
Exclusion Criteria:
- patients who refuse to be included, patients who have hypersensitivity to iodine, patients who have abnormal thyroid function, patients who do not visit follow-up, patients who have received prior radioactive-iodine therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: no intervention
|
|
Experimental: Povidone-iodine
povidone iodine pill
|
1 pill per biopsy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with febrile infection
Time Frame: 1 week
|
consider fever over 38 degree celsius or admission due to fever
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
voiding questionnaire
Time Frame: 1-2 week
|
check International Prostate Symptom Score (IPSS)
|
1-2 week
|
sexual function questionnaire
Time Frame: 1-2 week
|
International Index of Erectile Function-5 (IIEF-5)
|
1-2 week
|
quality of life questionnaire
Time Frame: 1-2 week
|
European Organization for Research and Treatment fo Cancer (EORTC) Quality of life Questionnaire (QLQ)-C30 questionnaire
|
1-2 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sangchul Lee, MD.PhD., Prof
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Anticipated)
October 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
September 10, 2014
First Submitted That Met QC Criteria
September 17, 2014
First Posted (Estimate)
September 19, 2014
Study Record Updates
Last Update Posted (Estimate)
September 22, 2014
Last Update Submitted That Met QC Criteria
September 18, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-1403/243-004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostatic Diseases
-
Boston Scientific CorporationCompletedProstatic Hyperplasia | Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | RezumDominican Republic, Czechia, Sweden
-
Boston Scientific CorporationCompletedBenign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | RezumDominican Republic
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
Janssen Research & Development, LLCActive, not recruitingCastration-Resistant Prostatic CancerUnited States, China, Italy, Korea, Republic of, Taiwan, Australia, Sweden, Belgium, Canada, France, Hungary, Israel, Malaysia, Russian Federation, Portugal, Germany, Bulgaria, Spain, Netherlands, Turkey, United Kingdom, Ukraine, Po... and more
Clinical Trials on Povidone-Iodine
-
DR. MALA KHANDhaka Medical CollegeCompleted
-
Norwegian University of Science and TechnologySt. Olavs HospitalTerminated
-
Stanford UniversityCompleted
-
Ikechukwu Bartholomew UlasiCompleted
-
Mahidol UniversityCompleted
-
Ain Shams UniversityRecruitingSurgical Wound Infection | Surgical Site InfectionEgypt
-
Hasan Kalyoncu UniversityActive, not recruiting
-
Assiut UniversityCompleted
-
William Beaumont HospitalsTerminatedUrinary Tract Infections | Catheter Infection | Catheter-Related Infections | Catheter; Infection (Indwelling Catheter) | Catheter BacteraemiaUnited States
-
Ain Shams Maternity HospitalUnknownInfection; Cesarean SectionEgypt